Evolent Health, Inc. Cash and Restricted Cash
Evolent Health, Inc. (EVH) had Cash and Restricted Cash of $141.47 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $141.47M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $168.74M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $180.70M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $143.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $141.47M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $168.74M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $180.70M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $143.00M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $177.97M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $277.85M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $178.50M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $127.85M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $137.95M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $233.48M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $223.46M 10-K · filed 2026-02-25 |
| 2023-09-30 | $224.50M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $207.60M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $191.97M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $215.16M 10-K · filed 2026-02-25 |
| 2022-09-30 | $194.82M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $280.43M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $262.79M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $354.94M 10-K · filed 2025-02-21 |
| 2021-09-30 | $281.75M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $238.41M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $303.77M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $361.58M 10-K · filed 2024-02-23 |
| 2020-09-30 | $400.55M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $153.21M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $129.80M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $128.53M 10-K · filed 2023-02-24 |
| 2019-09-30 | $205.75M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $137.17M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $227.45M 10-Q · filed 2020-05-28 |
| 2018-12-31 | $388.32M 10-K · filed 2022-02-24 |
| 2018-09-30 | $266.85M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $254.32M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $236.36M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $295.36M 10-K · filed 2021-02-26 |
| 2017-09-30 | $295.93M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $113.94M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $131.26M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $170.03M 10-K · filed 2020-03-02 |
| 2015-12-31 | $152.01M 10-K · filed 2019-02-28 |
| 2014-12-31 | $0.00 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |